Intellia Therapeutics NTLA
NASDAQ NTLA
$10.88 -0.53 (-4.69%)
As of: Nov 12, 2026 · 12:27 PM EST

Intellia Therapeutics (NTLA) Interest & Investment Income (2016 - 2026)

Updated

Intellia Therapeutics (NTLA) reported Interest & Investment Income of $5.8 million for Q2 2026, down 21.7% from $7.4 million a year earlier but up 11.4% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Interest & Investment Income (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Intellia Therapeutics' Interest & Investment Income came in at $24.19 million, down 37.6% year-over-year; for FY2025, it came in at $29.2 million, down 38.9% from FY2024.

  • Interest & Investment Income has a five-year compound annual growth rate of 65.5% (FY2020 to FY2025).
  • By year, Interest & Investment Income came in at $47.81 million in FY2024 (-4.1%), $49.83 million in FY2023 (+483.4%), $8.54 million in FY2022 (+565.8%) and $1.28 million in FY2021 (-45.5%).
  • Five-year quarterly Interest & Investment Income spans a low of $349,000 in Q3 2021 and a high of $12.74 million in Q3 2023.
  • Year over year, Interest & Investment Income has now declined in each of the last nine quarters, with an average decline of 29.6% over the last eight quarters.
  • The high point for year-over-year Interest & Investment Income in five years was Q4 2022 (growth of 964.4%); the low point was Q3 2025 (a decline of 44.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $5.21 million (Q1 2026), $6.48 million (Q4 2025) and $6.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Intellia Therapeutics 1.57 Bn -171.10 Mn - 5.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.84 Mn
Jun 30, 2026 5.80 Mn
Mar 31, 2026 5.21 Mn
Dec 31, 2025 6.48 Mn
Sep 30, 2025 6.71 Mn
Jun 30, 2025 7.40 Mn
Mar 31, 2025 8.60 Mn
Dec 31, 2024 10.63 Mn
Sep 30, 2024 12.12 Mn
Jun 30, 2024 12.42 Mn
Mar 31, 2024 12.63 Mn
Dec 31, 2023 12.46 Mn
Sep 30, 2023 12.74 Mn
Jun 30, 2023 12.65 Mn
Mar 31, 2023 11.98 Mn
Dec 31, 2022 5.35 Mn
Sep 30, 2022 1.95 Mn
Jun 30, 2022 703,000.00
Mar 31, 2022 540,000.00
Dec 31, 2021 503,000.00
API Access

Intellia Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NTLA&period=max&api_key=YOUR_API_KEY